N/A
N=118
Mobile App for Prenatal Care to Reduce Visits and Improve Satisfaction Study
Pregnancy
Bottom Line
View on ClinicalTrials.gov: NCT02914301 ↗Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: Total Visit Number — 7.9; 10.2 visits — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Babyscripts Prenatal App (Device); Placebo (Device)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Andrew Meltzer
- Primary completion
- Mar 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Visit Number |
7.9; 10.2 | <0.001 sig |
| SECONDARY Gestational Weight Gain |
22.9; 20.9; 34.0; 30.5; 35.0; 24.2 | — |
Summary
Prenatal care is defined as preventive healthcare characterized by regular check-ups by doctors or midwives to treat and prevent potential health problems throughout the course of the pregnancy. The investigators propose that a mobile app for prenatal care has the potential to provide patient-tailored, risk-appropriate prenatal educational content and may facilitate vital sign and weight checks between visits. The investigators describe the methods used to develop and test the effectiveness of a mobile app for prenatal care to safely reduce the number of in-person visits to the obstetrician (OB) compared to standard of care.
Eligibility Criteria
Inclusion Criteria
- Eligible participants will be women who are between 18 than 40-years-old, who are visiting the OB for a first-trimester verification of pregnancy visit, new OB visit or follow-up OB visit, who are low-risk per treating OB, who regularly use a smart-phone, who can understand and consent to English-written consent form.
- Eligible clinicians will be attending obstetric physicians who refer the patient to the research assistant for informed consent and full eligibility assessment.
Exclusion Criteria
- High-risk obstetrical condition*
- Intends midwifery care
- Intends to terminate
- Not Local resident
- Non--English speaker
Data sourced from ClinicalTrials.gov (NCT02914301). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.